Home > Healthcare > Skin Perfusion Pressure Testing Devices Market
Skin Perfusion Pressure Testing Devices Market Size, Share and Industry Analysis Report, Regional Outlook, Growth Potential, Competitive Market Share & Forecast, 2023 – 2032
- Report ID: GMI3988
Skin Perfusion Pressure Testing Devices Market size will gain remarkable traction between 2023 to 2032 on account of the growing focus on projecting compression therapies for patients with conditions, like foot ulcers.
Skin perfusion pressure test is largely favored as it is unaffected by moderate or minor edema and is hence performed on sites with thickened or callused skin. It covers non-invasive screening technique of small vessels that are successfully deployed for assessing the wound healing potential and determining the amputation levels.
The surging burden of chronic diseases, including diabetes along with the subsequently rising incidence of foot ulcers will propel the skin perfusion pressure testing devices market expansion. As per the USA Vascular Centers, over 80% of diabetic amputations start with foot ulcers. The rising number of peripheral artery diseases mainly amongst adults has also stirred the popularity of skin perfusion pressure treatment as an alternative to transcutaneous oxygen monitoring for evaluating capillary blood pressure of the skin.
Based on product type, the ultrasound skin perfusion pressure testing devices industry will amass massive gains by 2032. Ultrasound devices help assess structural changes and injuries to the soft-tissue structure of the foot. Increasing application scope in the prediction of wound healing in limb ischemia is another trend driving the product demand.
With regards to end-use, the skin perfusion pressure testing devices market share from ambulatory surgical centers is poised to depict notable growth rate through 2028. This can be attributed to the delivery of cost-effective diagnosis and preventive care services, such orthopedics and pain management, at ASCs.
Regionally, Asia Pacific market will attain traction through 2032 due to the strong presence of vast diabetic patient pool with unmet medical needs. It has been estimated that 80 million people have diabetes in India, and the number is likely to surge to 135 million by 2045. In the recent past, the public healthcare spending across various emerging economies has substantially escalated.
Some of the major players in the skin perfusion pressure testing devices market include Viasonix, Vasamed, Promed Group, Perimed, Moor Instruments, Koven Technology, ELCAT, CorVascular Diagnostics, and ADInstruments.
What Information does this report contain?
